About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight Blogs

Buy-Side Waking Up To MiFID II Impact On Research Fees, Says Fidessa Executive

Subscribe to our newsletter

In recent weeks, the understanding of how to implement the rules for commission payments set in Europe’s MiFID II regulation has changed, according to David Pearson, head of post-trade strategy at trading platform provider Fidessa.

“The understanding now is that a broker must be paid for services they provide to clients, whatever those services are,” Pearson said. “That also includes research. The buy-side is obligated to make sure it has a process and understands what research it needs — and the value of that research.

“[The regulation] completely changes the landscape of how existing brokers offer their research at a bundled rate, and [buy-side firms] get everything the firm actually issues,” he added. “The process of how research is procured is going to fundamentally change as a result of understanding the inducement which goes hand in hand with this particular space.”

Fidessa has partnered with commission management software provider Commcise to offer the capability to manage payment of fees for research in the manner required under MiFID II once it takes effect in January 2018.

Together, Fidessa and Commcise have taken an algorithmic approach to handling research fee payments, as Amrish Ganatra, managing director and co-founder of Commcise, explained.

“On a trade-by-trade basis, the allocations or accounts that feature part of the trade help determine exactly how much research commission to add on a given trade,” he said. “We make that decision based on looking at the budget for every given allocation within that trade. … We give the buy side the tools to determine what this extra research charge is on a trade-by-trade basis.”

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: GenAI and LLM case studies for Surveillance, Screening and Scanning

As Generative AI (GenAI) and Large Language Models (LLMs) move from pilot to production, compliance, surveillance, and screening functions are seeing tangible results – and new risks. From trade surveillance to adverse media screening to policy and regulatory scanning, GenAI and LLMs promise to tackle complexity and volume at a scale never seen before. But...

BLOG

Challenging the Status Quo: Re-imagining the Trading Desk for 2026 and Beyond

The opening session of A-Team Group’s recent TradingTech Summit Europe set a pragmatic tone for the discussions that followed. In a fireside chat between Stuart Lawrence, Head of EMEA Equity Trading at UBS Asset Management, and Monika Fernando, Product Leader, FinTech & Digital Platforms and former Head of Global FI Client Data & Analytics at...

EVENT

AI in Capital Markets Summit London

Now in its 3rd year, the AI in Capital Markets Summit returns with a focus on the practicalities of onboarding AI enterprise wide for business value creation. Whilst AI offers huge potential to revolutionise capital markets operations many are struggling to move beyond pilot phase to generate substantial value from AI.

GUIDE

AI in Capital Markets Handbook 2026

AI adoption in capital markets has moved into a more disciplined phase. The priority is now controlled deployment: where AI can be used safely, where it can deliver measurable value, and how outputs can be governed, monitored and evidenced. The 2026 edition of the AI in Capital Markets Handbook examines how AI is being applied...